These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33527905)
1. Mast cells (MC) excess in a bone marrow (BM) associated with lymphoplasmacytic cells (LPC) in a 55-Y-old patient with Waldenström's macroglobulinemia (WM). Gentelet M; Demulder A Ann Biol Clin (Paris); 2021 Feb; 79(1):92-93. PubMed ID: 33527905 [No Abstract] [Full Text] [Related]
2. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Tournilhac O; Santos DD; Xu L; Kutok J; Tai YT; Le Gouill S; Catley L; Hunter Z; Branagan AR; Boyce JA; Munshi N; Anderson KC; Treon SP Ann Oncol; 2006 Aug; 17(8):1275-82. PubMed ID: 16788002 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia. Jalali S; Ansell SM Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460 [TBL] [Abstract][Full Text] [Related]
4. Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia. Ahn A; Park CJ; Cho YU; Jang S; Seo EJ; Lee JH; Yoon DH; Suh C Ann Lab Med; 2020 May; 40(3):193-200. PubMed ID: 31858758 [TBL] [Abstract][Full Text] [Related]
5. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia. Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884 [TBL] [Abstract][Full Text] [Related]
6. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia. Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118 [TBL] [Abstract][Full Text] [Related]
8. CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders. Santos DD; Hatjiharissi E; Tournilhac O; Chemaly MZ; Leleu X; Xu L; Patterson C; Branagan AR; Manning RJ; Ho AW; Hunter ZR; Dimmock EA; Kutok JL; Churchill WH; Castells MC; Tai YT; Anderson KC; Treon SP Clin Lymphoma Myeloma; 2006 May; 6(6):478-83. PubMed ID: 16796779 [TBL] [Abstract][Full Text] [Related]
9. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related]
10. The epidemiology of Waldenström macroglobulinemia. McMaster ML Semin Hematol; 2023 Mar; 60(2):65-72. PubMed ID: 37099032 [TBL] [Abstract][Full Text] [Related]
11. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-3. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia (LPL/WM). Kobayashi Y Int J Hematol; 2019 Nov; 110(5):524-528. PubMed ID: 31494831 [No Abstract] [Full Text] [Related]
12. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia. Kyle RA; Ansell SM; Kapoor P Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464 [TBL] [Abstract][Full Text] [Related]
13. Mast cell density and its clinical relevance in Waldenström's macroglobulinemia. Lemal R; Poulain S; Ledoux-Pilon A; Veronese L; Tchirkov A; Lebecque B; Tassin T; Bay JO; Charlotte F; Nguyen-Khac F; Berger M; Godfraind C; Ysebaert L; Davi F; Pereira B; Leblond V; Hermine O; Guièze R; Pagès F; Tournilhac O EJHaem; 2022 May; 3(2):371-378. PubMed ID: 35846063 [TBL] [Abstract][Full Text] [Related]
14. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506 [TBL] [Abstract][Full Text] [Related]
15. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia. Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036 [TBL] [Abstract][Full Text] [Related]
16. Report of the Third International Workshop on Waldenstrom's macroglobulinemia. Treon SP; Morel P; Leblond V; Fermand JP Clin Lymphoma; 2005 Mar; 5(4):215-6. PubMed ID: 15794850 [No Abstract] [Full Text] [Related]
17. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121 [TBL] [Abstract][Full Text] [Related]
18. Waldenstrom's macroglobulinemia in the era of immunotherapy. Vaxman I; Gertz M Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730 [TBL] [Abstract][Full Text] [Related]